Effector Therapeutics Inc (EFTR)

US · Healthcare · Biotechnology

$0.000.00%

Last close · 2026-08-04

Latest quarter · ended 2024-03-31

Revenue

Net profit

$-8.8M

Profit YoY

+11.8%

EPS

$-2.16

EPS estimate

$-2.16

EPS came in at -2.16 against a street estimate of -2.16 — a beat of 0.0%.

Market cap

$940

Forward P/E

0.0

P/B

0.00

Book value

$0.21

EPS (TTM)

$-5.03

52-week high

$0.00

52-week low

$0.00

50-day MA

$0.00

200-day MA

$0.00

Beta

2.38

Analysts rate Effector Therapeutics Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $10.00.

Fund	Stake
Proathlete Wealth Management Llc	0.00%

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Effector Therapeutics Inc — free to start.

Data updated 2026-08-05.